Leaflet KINZALKOMB 80mg / 12.5mg tablets


Indicated for: hypertension

Route of administration: oral

Substance: telmisartan + hydrochlorothiazide (angiotensin II receptor blocker + diuretic)

ATC: C09DA07 (Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics)

Precautions:
Dose adjustment in renal impairment
Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Photosensitivity
Photosensitivity

Avoid excessive exposure to sunlight or UV radiation.

Hypotension / fall risk
Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests
Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances
Electrolyte disturbances

This medicine may change blood electrolyte levels.

This combination of telmisartan and hydrochlorothiazide is used for the treatment of hypertension in patients not adequately controlled with a single medication. Telmisartan blocks angiotensin II receptors, while hydrochlorothiazide is a diuretic that helps eliminate excess water and salt from the body.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and not discontinue treatment without consulting their doctor.

Patients should be aware of potential side effects, such as dizziness, electrolyte imbalances, or nausea. It is important to inform the doctor of any unusual symptoms.

Common side effects include dizziness, electrolyte imbalances, nausea, and fatigue. In rare cases, severe reactions such as kidney failure or allergic reactions may occur. Patients should be informed of these risks before starting treatment.

General data about KINZALKOMB 80mg / 12.5mg

  • Substance: telmisartan + hydrochlorothiazide
  • Date of last drug list: 01-07-2013
  • Commercial code: W51549002
  • Concentration: 80mg / 12.5mg
  • Pharmaceutical form: tablets
  • Quantity: 28
  • Product type: original
  • Prescription restrictions: P-6L - Medicines prescription that isn't retained in the pharmacy (can be renewed); the prescription can be used for 6 months from the moment of release.

Pharmaceutical forms available for telmisartan + hydrochlorothiazide

Concentrations available for telmisartan + hydrochlorothiazide

  • 40/12.5mg
  • 40mg/12.5mg
  • 80/25mg
  • 80mg/12.5mg
  • 80mg/25mg